Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
Sponsor: Response Pharmaceuticals
Summary
The purpose is to determine the effect of SLx-2101 dosed at 5mg or 10mg for 14 days on systolic, diastolic pressures and heart rate in patients with hypertension.
Official title: A Pilot Phase IIa Randomised, Double-blind, Placebo-controlled, Crossover Study to Examine the Safety, Tolerability and Pharmacodynamic Effects on Blood Pressure of Repeat Oral Doses of SLx-2101 5 mg or 10 mg Once Daily for up to 14 Days in Patients With Hypertension
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
38
Start Date
2007-06
Completion Date
2007-12
Last Updated
2026-04-24
Healthy Volunteers
No
Conditions
Interventions
SLx-2101
Locations (1)
Parexel, Institute for Clinical Pharmacology
Berlin, Germany